Softwr

Healthcare · head to head

RXNT vs Therapixel

RXNT logo

RXNT

Healthcare

Cloud practice management and EHR software with a la carte modules

From
On request
Rated
-
Therapixel logo

Therapixel

Healthcare

French mammography AI with FDA clearances for 2D and tomosynthesis breast screening

From
On request
Rated
-

The short version

  • Each has a real cost: RXNT specific pricing tiers not displayed; plans reference starting at $118/month; Therapixel european and American regulatory positions were established under different regimes, and under the EU Medical Device Regulation this class of diagnostic AI faces a higher classification and notified body scrutiny, so European buyers must verify the current MDR certificate and expiry rather than relying on a legacy CE reference.
  • Prices and features above were last checked on 1 September 2026.

Where they differ

Only the attributes on which RXNT and Therapixel actually diverge.

Attributes where RXNT and Therapixel differ
AttributeRXNTTherapixel
Pricing modelsubscriptionquote

Identical on both: starting price (On request), free tier (No), platforms (Web), user rating (Not yet rated), category (Healthcare).

What each one covers

Drawn from each product's published feature list. An absence here means we hold no record of it - not that the product lacks it.

Only in RXNT

Nothing recorded that Therapixel does not also cover.

Only in Therapixel

  • MammoScreen 2D
  • MammoScreen DBT
  • One to ten suspicion score
  • Summary report
  • Workstation and PACS delivery
  • Reading workflow configurations

What people use each for

The jobs each tool is most often brought in to do.

RXNT

  • Running entire medical practices from single integrated platformnot Therapixel
  • Managing electronic prescriptions including controlled Schedule II-V drugsnot Therapixel
  • Streamlining billing and claims management with unlimited claim processingnot Therapixel
  • Supporting specialty workflows for mental health and hospice providersnot Therapixel
  • Capturing appointment reminders and patient billing through patient portalnot Therapixel

Therapixel

  • A European breast screening programme running mandatory double reading that wants to evaluate AI as a concurrent or second reader within what national guidance permitsnot RXNT
  • An American breast centre that has moved to tomosynthesis and needs reading support on DBT specifically, which Therapixel holds a clearance fornot RXNT
  • A screening service wanting a graded suspicion score rather than a binary flag so readers can calibrate their own thresholdnot RXNT
  • A radiology group evaluating multiple mammography AI vendors head to head on their own historic case set before committingnot RXNT

Where each one falls short

Documented limitations, not opinions. Every one is a constraint you would hit in normal use.

RXNT

  • Specific pricing tiers not displayed; plans reference starting at $118/month
  • E-prescribing only available with yearly subscription
  • Requires contacting sales for personalized pricing

Therapixel

  • European and American regulatory positions were established under different regimes, and under the EU Medical Device Regulation this class of diagnostic AI faces a higher classification and notified body scrutiny, so European buyers must verify the current MDR certificate and expiry rather than relying on a legacy CE reference.
  • MammoScreen does mammography only, so a hospital wanting AI across head CT, chest and breast needs several vendors and several PACS integrations, or an orchestration layer bought from someone else.
  • Therapixel is a small French company competing against Hologic and iCAD, which have incumbency inside the mammography reading workstation, so integration into an American breast centre is more work than it is for the workstation vendor own AI.
  • Detection performance is sensitive to the mammography unit vendor and acquisition protocol, so published results do not transfer between estates and each site needs local validation it must fund itself.
  • Whether AI can substitute for one of two human readers is a national workforce and liability question, not a product capability, so the labour saving that justifies the purchase in one country is not permitted in another.

Pricing, plan by plan

RXNT

On request

No published plan breakdown. See the RXNT review.

Therapixel

On request
  • MammoScreen$undefined/year
    • Priced per examination or by annual screening volume
    • 2D and tomosynthesis licensed by the versions cleared for each
    • Cloud or on premises deployment quoted differently

Which should you pick?

Choose RXNT if

Nothing in the data separates RXNT from Therapixel on the points above - pick on price and on how each one feels to use.

Choose Therapixel if

  • You need mammoscreen 2d.
  • You also want mammoscreen dbt.

Questions people ask

Is RXNT or Therapixel better?
Neither clearly leads. RXNT starts at On request and Therapixel at On request, and user ratings are close enough to be indistinguishable. Choose on capability and platform support.
Which is cheaper, RXNT or Therapixel?
RXNT starts at On request and Therapixel at On request.
Does RXNT or Therapixel run on more platforms?
Both run on Web, so platform support will not decide this one for you.
What is RXNT best used for?
RXNT is most often used for running entire medical practices from single integrated platform, managing electronic prescriptions including controlled schedule ii-v drugs, streamlining billing and claims management with unlimited claim processing, supporting specialty workflows for mental health and hospice providers. Of those, running entire medical practices from single integrated platform and managing electronic prescriptions including controlled schedule ii-v drugs are not what Therapixel is typically brought in for.
What can RXNT do that Therapixel cannot?
Therapixel covers MammoScreen 2D, MammoScreen DBT, One to ten suspicion score, Summary report.

Answered from the vendors’ own pages

RXNT: What is RXNT's pricing model?

RXNT offers a-la-carte and bundled subscription options with monthly or annual billing. Annual subscriptions receive a 10% discount. Pricing starts at $118/month, though specific tier pricing is not displayed.

Source
Therapixel: Is MammoScreen FDA cleared?

Yes. It holds 510(k) clearance K192854 for two dimensional mammography from July 2020, a November 2021 clearance for digital breast tomosynthesis, and two further clearances in October 2024 for later versions.

RXNT: What are the additional costs for RXNT?

RXNT charges $85 per year for EPCS (Electronic Prescribing of Controlled Substances) including ID proofing and biometric authentication. Non-prescribing staff also have license fees, and data imports and extended onboarding are available at additional cost.

Source
Therapixel: Is it CE marked?

Yes, but European buyers should ask specifically for the current certificate under the Medical Device Regulation and its expiry date, because this class of diagnostic AI moved to a higher classification under MDR.

RXNT: What onboarding support does RXNT provide?

RXNT includes 45 days of onboarding with the EHR Bundle and 60 days with the Practice Management and Full Suite bundles.

Source
Therapixel: What does the one to ten score mean?

It is a graded suspicion score per finding and per study, designed to be integrated alongside a radiologist BI-RADS assessment rather than treated as a positive or negative result.

Therapixel: Does it cover anything besides mammography?

No. It is a mammography product only, including tomosynthesis. Other body regions need a different vendor.

Share

Related pages

Other head to heads